WASHINGTON (Sept. 11, 2015) - A statement from American College of Cardiology President Kim Allan Williams Sr., M.D., FACC, regarding the National Institutes of Health stopping the SPRINT trial early after demonstrating the positive benefits of lower blood pressure control targets:
"About 70 million American adults have high blood pressure and only half of them have their condition under control. The preliminary data demonstrates why the cardiovascular community must continue to aggressively fight a condition that leads to stroke, kidney disease and heart problems for our patients," said American College of Cardiology President Kim Allan Williams Sr., M.D., FACC. "The details of the SPRINT trial will be a contributing factor to future guidelines on blood pressure treatment targets. In the meantime, this data gives physicians more information to consider when working to improve outcomes for our patients with high blood pressure."
The American College of Cardiology is a 49,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, promotes cardiovascular research and bestows credentials on cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.